How Do Patients Understand Safety for Cardiac Implantable Devices? Importance of Postintervention Education
Table 2
Diagnosis, underlying etiology, type/mode and lifetime of the cardiac implantable electronic device (CIED), and generator replacement number of the patients.
Patients with education Number (%) (n:28)
Patients without education Number (%) (n:93)
Diagnosis
Sinus Node Dysfunction
8 (28.5)
31 (33.3)
Atrioventricular Node Dysfunction
11 (39.2)
37 (39.8)
Ventricular Tachycardia/Fibrillation
6 (21.4)
10 (10.7 )
Severe Heart Failure
3 (10.7)
15 (16.2)
Etiology
Ischemic Heart Disease
6 (21.4)
30 (32.2)
Post-Myocardial Infarction
1 (3.6)
5 (5.3)
Cardiomyopathy
13 (46.4)
11 (11.8)
Degenerative
2 (7.1)
28 (30.1)
Iatrogenic
-
3 (3.2)
Idiopathic
6 (21.4)
16 (17.2)
CIED type or mode
VVI
1 (3.6)
12 (12.9)
VDDR
5 (17.9)
20 (21.5)
DDDR
3 (10.7)
33 (35.4)
ICD (DDD or VVI)
11 (39.28)
18 (19.4)
ICD-CRT
8 (28.6)
10 (10.8)
Polarity
Unipolar
5 (17.9)
30 (32.6)
Bipolar
19 (67.9)
63 (67.7)
Utility time of current device (months)
1.36±0.5
55.21±46.8
According to NASPE/BPEG Generic Pacemaker Code (NBG), 2002. ICD: implantable cardioverter-defibrillators. ICD-CRT: implantable cardioverter-defibrillators and cardiac resynchronization therapy.
